WAM
NVAX icon

Wolverine Asset Management’s Novavax NVAX Stock Holding History

Wolverine Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,767
Closed -$106K – 1837
2023
Q4 		$109K Hold
22,767
– – ﹤0.01% 1119
2023
Q3 		$165K Sell
22,767
-35,383
-61% -$283K ﹤0.01% 1072
2023
Q2 		$432K Sell
58,150
-291,850
-83% -$2.3M 0.01% 875
2023
Q1 		$2.43M Buy
+350,000
New +$3.22M 0.03% 474
2022
Q4 		– Sell
-65,038
Closed -$1.15M – 2249
2022
Q3 		$1.18M Buy
+65,038
New +$2.82M 0.01% 740
2021
Q3 		– Sell
-666
Closed -$147K – 2238
2021
Q2 		$141K Buy
+666
New +$122K ﹤0.01% 1373
2020
Q4 		– Sell
-2,787
Closed -$296K – 1816
2020
Q3 		$301K Buy
+2,787
New +$340K ﹤0.01% 870
2020
Q2 		– Sell
-7,437
Closed -$284K – 1706
2020
Q1 		$100K Sell
7,437
-6,995
-48% -$59.2K ﹤0.01% 1046
2019
Q4 		$57K Buy
+14,432
New +$62.6K ﹤0.01% 1172
2019
Q2 		– Sell
-4,256
Closed -$33.5K – 1553
2019
Q1 		$46K Buy
4,256
+576
+16% +$18.2K ﹤0.01% 1190
2018
Q4 		$135K Buy
+3,680
New +$143K ﹤0.01% 1310

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Asset Management's NVAX Position: Q1 2024 in Review

Wolverine Asset Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 22,767 shares — an estimated $106K sold.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and held it in 11 quarters. The position peaked at $2.43M in Q1 2023. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Wolverine Asset Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 22,767 Novavax shares in Q1 2024, an estimated $106K.
  • Wolverine Asset Management first reported a position in Novavax in Q4 2018 and held it in 11 quarters.
  • Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.